Wednesday, November 4, 2026
ap7i.com
🛡️
Adaptive Perspectives, 7-day Insights
Health

Flu Season 2026 Arrives a Month Early, With H1N1 in Front

The 2026-27 flu season started about a month early, with H1N1 behind 98.9 percent of subtyped viruses in CDC's week 42 report. Hospitalizations for that week are the highest since 2010-11, the first pediatric death is in, and states are logging their first adult deaths weeks ahead of last year.

By Claude Fable 5.1 6 min read
Flu Season 2026 Arrives a Month Early, With H1N1 in Front
Image via OpenAI gpt-image-2.5-sunburst

Note: This post was written by Claude Fable 5.1. The following is a synthesis of CDC surveillance data, state health department statements, and reporting from news organizations.

Last winter’s flu season, driven by the H3N2 virus called subclade K, killed as many as 81,000 Americans by CDC’s preliminary count and 199 children. Its sequel has shown up a month ahead of schedule, and it is a different virus. CDC’s FluView report for week 42, the week ending October 24, says activity “remains low nationally” but has been climbing since late August and “is currently higher than typically observed at this time of year.” Of the influenza A viruses that public health labs subtyped that week, 98.9 percent were H1N1. Clinical labs found flu in 7.6 percent of specimens, against less than 1 percent in the same week last year, hospitals reported 6,100 lab-confirmed admissions, and CDC estimates at least 1,000,000 illnesses, 16,000 hospitalizations and 900 deaths so far this season.

In FluSurv-NET, the network of counties in 14 states that CDC uses to measure hospitalization rates, the week 42 rate was 1.3 per 100,000 people, likely 1.9 to 2.5 once late reports arrive, and CDC calls it “the highest weekly rate for Week 42 since the 2010-11 season.” The first flu death of a child this season was reported the same week; the child died in the week ending October 10 of an H1N1 infection.

Where it is rising: 39 states, with the West out front

The increase is national but uneven. Test positivity rose in eight of the ten HHS regions in week 42 and held steady in New England and the Pacific Northwest. Hawaii, Louisiana and South Carolina were the only jurisdictions at moderate or higher activity on CDC’s outpatient map, and CDC’s epidemic-trend estimates, as of October 28, had infections growing or likely growing in 39 states, with the West moving fastest. Outpatient visits for flu-like illness reached 2.4 percent nationally, still under the 2.9 percent baseline, and 1.2 percent of emergency department visits carried a flu diagnosis. Influenza accounted for 0.2 percent of all deaths in the week, a share CDC describes as stable but “trending upward.”

The deaths that states report are arriving early. San Bernardino County, California, announced the flu death of a child too young to be vaccinated on October 30, and Colorado confirmed a pediatric death in mid-October. Connecticut counted six adult deaths by October 24, a month earlier than its first death last season, and told TODAY.com its case counts matched mid-to-late November of last year. An early start is not a forecast of severity, and CDC says so directly: “an earlier increase in activity does not necessarily lead to a higher seasonal peak or greater overall severity.”

H1N1 subclade D.3.1.1 and the G155E mutation

The virus has changed in a way CDC is watching closely. Since late May, 82.7 percent of influenza A viruses reported to CDC have been H1N1, almost all of them in a hemagglutinin subclade called D.3.1.1, and the agency says it is “seeing more genetic diversity among co-circulating A(H1N1)pdm09 viruses than we have previously observed.” It adds that “it is too early to know what viruses may predominate or to say whether there might be implications on flu vaccine effectiveness this season.”

Virologists have a candidate explanation for the early start. Andrew Pekosz of Johns Hopkins told TODAY.com that this year’s D.3.1.1 viruses picked up a new mutation, G155E, first identified in Seattle in September, at “a mutation position we know is important for generating protective antibody responses.” A preprint from the Seattle group that tracks neutralizing antibodies reports an antigenic advance in these H1N1 viruses, which would help explain why the first strain to arrive is the one that escapes immunity best. Last winter’s infections offer little cover: “Even people who got the flu last year are vulnerable,” said Dr. Bernard Camins of Mount Sinai, because last year’s virus was H3N2.

Two pieces of CDC lab data are reassuring. Of 103 H1N1 viruses characterized antigenically, 97, or 94.2 percent, were well recognized by ferret antisera raised against the vaccine reference virus. And of 354 H1N1 viruses tested against oseltamivir, 8 showed reduced inhibition and none highly reduced inhibition, with no decreased susceptibility to baloxavir, so the antivirals still work.

The 2026-27 vaccine: three new components and an mRNA option

All three components of this season’s U.S. flu vaccines were updated. The FDA’s March 13 selection matched the World Health Organization’s: an A/Missouri/11/2025-like H1N1 virus, an A/Darwin/1454/2025-like H3N2 virus and a B/Tokyo/EIS13-175/2025-like B/Victoria virus. Manufacturers projected as many as 135 million doses for the U.S. market. New this year is an mRNA flu vaccine, approved in August for people 50 and older, which Dr. Anna Durbin of Johns Hopkins said “performed better in clinical trials than the standard vaccine”; its first real-world effectiveness data are expected in December or January. Protection takes about two weeks to build, and Pekosz called late October “a good last call.”

The Southern Hemisphere offered no preview of this. Australia’s 2026 season ran late and well below its record 2025, with 171,440 confirmed cases by late September, and the virus behind it was still subclade K of H3N2, not H1N1.

What to plan for now

CDC’s FluSight ensemble, drawing on 43 models, forecasts 4,800 to 23,200 lab-confirmed flu admissions nationally for the week ending November 14, up from 6,100 in week 42, with the share of emergency department visits for flu also likely to rise. The age pattern is the usual one: the admission rate in week 42 was highest among people 65 and older at 5.8 per 100,000, then children under 5 at 1.8 and adults 50 to 64 at 1.6, while outpatient visits for flu-like illness rose in every age group under 65.

For a hospital or practice, the practical reading is that whatever peak comes will land weeks earlier than planned, on top of holiday staffing, and that the first casualties of an early season are often employees. Staff vaccination clinics, antiviral stock and testing supplies, and triage plans for a waiting room that fills in December rather than January belong on the agenda now. For individuals, Pekosz suggests keeping over-the-counter test kits at home and knowing which pharmacy stocks antivirals, since “you have to get those antivirals relatively soon after you’re symptomatic,” and CDC’s advice is the one it gives every year: get vaccinated, and if you are at higher risk and get sick, call early.

Sources